Screener
Neogen NEOG Business Segments
| Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Animal Safety | $59.6M+4.4% | $58.5M-8.2% | $54.5M-20.1% | $59.14M-11.8% | $57.1M-0.9% | |
| Food Safety | $163.2M+7.3% | $166.8M+3.1% | $156.7M+2.6% | $165.55M+0.8% | $152.1M-4.5% | |
| Revenue by Product | ||||||
| Animal Care And Other | $7.7M+1.3% | $7M-12.5% | $5.9M-43.3% | $8.8M-10.0% | $7.6M+13.8% | |
| Bacterial And General Sanitation | $44.6M+7.2% | $46.7M+9.9% | $42.1M+5.5% | $44.92M+5.6% | $41.6M+4.3% | |
| Biosecurity Products | $23.5M-6.0% | —— | $18.9M-46.9% | $22.51M-33.9% | $25M-23.3% | |
| Genomics Services | $24M+8.6% | $23.8M+4.4% | $22.8M+0.4% | $23.44M+5.5% | $22.1M+3.0% | |
| Indicator Testing And Culture Media | $85.6M+11.5% | $86.8M+9.5% | $83M+11.0% | $86.11M+8.2% | $76.8M-2.2% | |
| Life Sciences | $1.6M-15.8% | $1.8M+12.5% | $1.5M0.0% | $1.45M-11.0% | $1.9M+9.6% | |
| Natural Toxins And Allergens | $19.3M-3.5% | $19.2M+3.8% | $17.9M+1.7% | $20.44M-0.3% | $20M-1.8% | |
| Other | $2.4M+4.3% | $3.6M-7.7% | $3.6M+20.0% | $3.27M-13.4% | $2.3M-23.8% | |
| Veterinary Instruments And Consumables | $14.1M+18.5% | —— | —— | —— | $11.9M— | |
| Revenue by Geography | ||||||
| Non Us | $112.7M+5.2% | $115M+1.8% | $108.9M+3.1% | $114.26M-2.8% | $107.1M-4.9% | |
| US | $110.1M+7.8% | $110.3M-2.0% | $102.3M-11.4% | $110.44M-2.9% | $102.1M-2.2% |
FAQ
- How does Neogen break its business down?
- Neogen (NEOG) reports revenue by business across 2 parts — Animal Safety and Food Safety. Each is extracted from the segment footnotes and tracked over time.
- Where does Neogen's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Neogen's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
